| Name | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
| Description | The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSMARCA4, also known as BRG1, is a pivotal ATPase subunit of the SWI/SNF chromatin‐remodeling complex that orchestrates dynamic nucleosomal reorganization and regulates gene expression in diverse biological settings. Its downregulation by macrophage‐derived microRNAs has been shown to promote colorectal cancer cell migration and invasion, underscoring its importance in controlling metastatic behavior."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In the developing heart, SMARCA4 regulates cardiomyocyte proliferation and directs the fetal‐to‐adult myosin heavy chain switch – a process that becomes reactivated under cardiac stress, contributing to pathological hypertrophy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " By interacting with the transcription factor ZEB1, SMARCA4 plays a key role in repressing E‐cadherin expression to promote epithelial‐to‐mesenchymal transition (EMT) during tumor invasion"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ", while its participation in complexes with p53 supports its function in cell‐cycle control and tumor suppression"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, SMARCA4 is required for glucocorticoid receptor–mediated trans‐repression of proopiomelanocortin and for facilitating Nrf2‐dependent induction of antioxidant genes"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "and"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ", and it localizes to critical enhancer elements in hematopoietic cells to shape cell‐type–specific transcriptional programs."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Its mechanistic role is further underscored by studies demonstrating that SMARCA4 mutants disrupt enhancer accessibility and nucleosome remodeling dynamics"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "and"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ", while its participation in signal‐dependent pathways is evident from its interaction with SMAD transcription factors during TGF‑β signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn oncogenesis, inactivating mutations and loss of SMARCA4 expression have emerged as critical events in several aggressive malignancies. Germline mutations in SMARCA4 predispose to small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "15"}]}, {"type": "t", "text": ", and"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": ", while its loss in non‐small cell lung cancers correlates with adverse outcomes"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "27"}]}, {"type": "t", "text": ", and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": " In these contexts, defective SMARCA4 impairs chromatin remodeling processes that maintain genomic stability and proper cell cycle checkpoints, thereby facilitating malignant transformation, enhanced invasiveness, and dedifferentiation. Notably, such loss of function disrupts tumor‐suppressive networks and cellular adhesion that normally restrain metastatic progression (for example, via perturbation of p53‐mediated regulation and altered chromatin states)."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nEmerging evidence has further revealed that SMARCA4 deficiency creates exploitable therapeutic vulnerabilities. Synthetic‐lethal approaches targeting its paralog SMARCA2, as well as the use of EZH2 and oxidative phosphorylation inhibitors, show promise in preclinical models"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "30", "end_ref": "33"}]}, {"type": "t", "text": ", and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "34"}]}, {"type": "t", "text": " Restoration of SMARCA4 function reengages transcriptional circuits controlling cell differentiation, as evidenced by its role in configuring enhancer landscapes in both hematopoietic and melanocytic lineages"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "35"}]}, {"type": "t", "text": "and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "36"}]}, {"type": "t", "text": " Moreover, aberrant enhancer reprogramming linked to SMARCA4 loss has been implicated in further modulation of lineage‐determining transcriptional networks (for instance, through altered chromatin interactions affecting global gene expression patterns ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "37"}]}, {"type": "t", "text": "]), while its regulatory influence over differentiation is also observed in melanocytes and other cell types"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "38", "end_ref": "40"}]}, {"type": "t", "text": ", and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "41"}]}, {"type": "t", "text": " Finally, aberrant chromatin remodeling by SMARCA4 also impacts vascular smooth muscle cell function, contributing to epigenetic repression of contractile gene expression and the pathogenesis of aortic aneurysms."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "42"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jingqin Lan, Li Sun, Feng Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-18-0014"}], "href": "https://doi.org/10.1158/0008-5472.CAN-18-0014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30401711"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30401711"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Calvin T Hang, Jin Yang, Pei Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chromatin regulation by Brg1 underlies heart muscle development and disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature09130"}], "href": "https://doi.org/10.1038/nature09130"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20596014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20596014"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "E Sánchez-Tilló, A Lázaro, R Torrent, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.102"}], "href": "https://doi.org/10.1038/onc.2010.102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20418909"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20418909"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Bin Guan, Tian-Li Wang, Ie-Ming Shih "}, {"type": "b", "children": [{"type": "t", "text": "ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-11-1562"}], "href": "https://doi.org/10.1158/0008-5472.CAN-11-1562"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21900401"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21900401"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Daeyoup Lee, Jin Woo Kim, Taegun Seo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111987200"}], "href": "https://doi.org/10.1074/jbc.M111987200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11950834"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11950834"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Steve Bilodeau, Sophie Vallette-Kasic, Yves Gauthier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.1444606"}], "href": "https://doi.org/10.1101/gad.1444606"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17043312"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17043312"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jianyong Zhang, Tsutomu Ohta, Atsushi Maruyama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00700-06"}], "href": "https://doi.org/10.1128/MCB.00700-06"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16923960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16923960"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Gangqing Hu, Dustin E Schones, Kairong Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genome Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gr.121145.111"}], "href": "https://doi.org/10.1101/gr.121145.111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21795385"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21795385"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "H Courtney Hodges, Benjamin Z Stanton, Katerina Cermakova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41594-017-0007-3"}], "href": "https://doi.org/10.1038/s41594-017-0007-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29323272"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29323272"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "G J Narlikar, M L Phelan, R E Kingston "}, {"type": "b", "children": [{"type": "t", "text": "Generation and interconversion of multiple distinct nucleosomal states as a mechanism for catalyzing chromatin fluidity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s1097-2765(01)00412-9"}], "href": "https://doi.org/10.1016/s1097-2765(01"}, {"type": "t", "text": "00412-9) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11779498"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11779498"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Qiaoran Xi, Wei He, Xiang H-F Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M707479200"}], "href": "https://doi.org/10.1074/jbc.M707479200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18003620"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18003620"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Leora Witkowski, Jian Carrot-Zhang, Steffen Albrecht, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2931"}], "href": "https://doi.org/10.1038/ng.2931"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24658002"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24658002"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Pilar Ramos, Anthony N Karnezis, David W Craig, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2928"}], "href": "https://doi.org/10.1038/ng.2928"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24658001"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24658001"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Petar Jelinic, Jennifer J Mueller, Narciso Olvera, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recurrent SMARCA4 mutations in small cell carcinoma of the ovary."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2922"}], "href": "https://doi.org/10.1038/ng.2922"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24658004"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24658004"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Francois Le Loarer, Sarah Watson, Gaelle Pierron, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.3399"}], "href": "https://doi.org/10.1038/ng.3399"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26343384"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26343384"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Reinhard Schneppenheim, Michael C Frühwald, Stefan Gesk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2010.01.013"}], "href": "https://doi.org/10.1016/j.ajhg.2010.01.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20137775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20137775"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "David N Reisman, Janiece Sciarrotta, Weidong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12566296"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12566296"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Shilpa Kadam, Beverly M Emerson "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s1097-2765(03)00034-0"}], "href": "https://doi.org/10.1016/s1097-2765(03"}, {"type": "t", "text": "00034-0) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12620226"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12620226"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Pedro P Medina, Octavio A Romero, Takashi Kohno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.20730"}], "href": "https://doi.org/10.1002/humu.20730"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18386774"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18386774"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Adam J Schoenfeld, Chai Bandlamudi, Jessica A Lavery, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Genomic Landscape of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SMARCA4"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Alterations and Associations with Outcomes in Patients with Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-20-1825"}], "href": "https://doi.org/10.1158/1078-0432.CCR-20-1825"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32709715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32709715"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "K-Y Tai, Y-S Shieh, C-S Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2008.57"}], "href": "https://doi.org/10.1038/onc.2008.57"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18345028"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18345028"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Octavio A Romero, Manuel Torres-Diz, Eva Pros, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Discov (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2159-8290.CD-13-0799"}], "href": "https://doi.org/10.1158/2159-8290.CD-13-0799"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24362264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24362264"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Sheng Wang, Baohua Zhang, Douglas V Faller "}, {"type": "b", "children": [{"type": "t", "text": "Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/emboj/cdf302"}], "href": "https://doi.org/10.1093/emboj/cdf302"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12065415"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12065415"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "William D Foulkes, Junne Kamihara, D Gareth R Evans, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-17-0595"}], "href": "https://doi.org/10.1158/1078-0432.CCR-17-0595"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28620006"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28620006"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Erica Hlavin Bell, Arup R Chakraborty, Xiaokui Mo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-15-1468"}], "href": "https://doi.org/10.1158/1078-0432.CCR-15-1468"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26671993"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26671993"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Christian L Lino Cardenas, Chase W Kessinger, Yisha Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-03394-7"}], "href": "https://doi.org/10.1038/s41467-018-03394-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29520069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29520069"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Matthias Weider, Melanie Küspert, Melanie Bischof, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chromatin-remodeling factor Brg1 is required for Schwann cell differentiation and myelination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Cell (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.devcel.2012.05.017"}], "href": "https://doi.org/10.1016/j.devcel.2012.05.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22814607"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22814607"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Matthew W Strobeck, David N Reisman, Ranjaka W Gunawardena, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109532200"}], "href": "https://doi.org/10.1074/jbc.M109532200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11719516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11719516"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Takahiro Oike, Hideaki Ogiwara, Yuichi Tominaga, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-12-4593"}], "href": "https://doi.org/10.1158/0008-5472.CAN-12-4593"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23872584"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23872584"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Emily C Dykhuizen, Diana C Hargreaves, Erik L Miller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BAF complexes facilitate decatenation of DNA by topoisomerase IIα."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature12146"}], "href": "https://doi.org/10.1038/nature12146"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23698369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23698369"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Junya Fukuoka, Takeshi Fujii, Joanna H Shih, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-03-0489"}], "href": "https://doi.org/10.1158/1078-0432.CCR-03-0489"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15240517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15240517"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Boris G Wilson, Katherine C Helming, Xiaofeng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01372-13"}], "href": "https://doi.org/10.1128/MCB.01372-13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24421395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24421395"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Abbas Agaimy, Ondrej Daum, Bruno Märkl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAS.0000000000000554"}], "href": "https://doi.org/10.1097/PAS.0000000000000554"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26551623"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26551623"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Yonathan Lissanu Deribe, Yuting Sun, Christopher Terranova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41591-018-0019-5"}], "href": "https://doi.org/10.1038/s41591-018-0019-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29892061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29892061"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Elena Battaglioli, Maria E Andrés, Dave W Rose, et al. "}, {"type": "b", "children": [{"type": "t", "text": "REST repression of neuronal genes requires components of the hSWI.SNF complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M205691200"}], "href": "https://doi.org/10.1074/jbc.M205691200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12192000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12192000"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Anthony N Karnezis, Yemin Wang, Pilar Ramos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/path.4633"}], "href": "https://doi.org/10.1002/path.4633"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26356327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26356327"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Akihiko Yoshida, Eisuke Kobayashi, Takashi Kubo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2017.11"}], "href": "https://doi.org/10.1038/modpathol.2017.11"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28256572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28256572"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Mei Huang, Feng Qian, Yuanyu Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb855"}], "href": "https://doi.org/10.1038/ncb855"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12244326"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12244326"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Patrick Laurette, Thomas Strub, Dana Koludrovic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.06857"}], "href": "https://doi.org/10.7554/eLife.06857"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25803486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25803486"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Elayne Chan-Penebre, Kelli Armstrong, Allison Drew, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "In Vitro"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "In Vivo"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Preclinical Models."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-16-0678"}], "href": "https://doi.org/10.1158/1535-7163.MCT-16-0678"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28292935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28292935"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "K Schramedei, N Mörbt, G Pfeifer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.15"}], "href": "https://doi.org/10.1038/onc.2011.15"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21317927"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21317927"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Shuwei Wang, Xiwu Zhang, Yang Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Cardiothorac Surg (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/ejcts/ezu215"}], "href": "https://doi.org/10.1093/ejcts/ezu215"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24875884"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24875884"}]}]}]}
|
| Synonyms | CSS4, HSNF2B, SNF2L4, MRD16, BRG1, RTPS2, BAF190A |
| Proteins | SMCA4_HUMAN |
| NCBI Gene ID | 6597 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SMARCA4 has 14,716 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 149 datasets.
Click the + buttons to view associations for SMARCA4 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by SMARCA4 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SMARCA4 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SMARCA4 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SMARCA4 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SMARCA4 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SMARCA4 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SMARCA4 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving SMARCA4 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SMARCA4 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SMARCA4 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SMARCA4 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SMARCA4 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SMARCA4 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SMARCA4 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with SMARCA4 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SMARCA4 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SMARCA4 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SMARCA4 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SMARCA4 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SMARCA4 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with SMARCA4 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with SMARCA4 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing SMARCA4 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SMARCA4 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SMARCA4 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SMARCA4 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing SMARCA4 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing SMARCA4 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SMARCA4 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SMARCA4 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing SMARCA4 protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SMARCA4 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SMARCA4 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SMARCA4 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SMARCA4 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with SMARCA4 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving SMARCA4 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving SMARCA4 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with SMARCA4 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SMARCA4 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SMARCA4 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SMARCA4 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SMARCA4 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SMARCA4 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SMARCA4 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SMARCA4 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SMARCA4 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SMARCA4 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SMARCA4 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SMARCA4 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SMARCA4 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SMARCA4 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SMARCA4 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SMARCA4 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SMARCA4 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SMARCA4 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SMARCA4 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SMARCA4 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SMARCA4 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SMARCA4 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SMARCA4 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SMARCA4 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SMARCA4 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SMARCA4 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SMARCA4 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SMARCA4 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SMARCA4 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SMARCA4 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SMARCA4 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SMARCA4 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SMARCA4 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SMARCA4 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SMARCA4 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with SMARCA4 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SMARCA4 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SMARCA4 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SMARCA4 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SMARCA4 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SMARCA4 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SMARCA4 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SMARCA4 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SMARCA4 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of SMARCA4 protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with SMARCA4 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SMARCA4 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SMARCA4 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SMARCA4 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SMARCA4 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SMARCA4 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SMARCA4 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate SMARCA4 protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways 2026 | pathways involving SMARCA4 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate SMARCA4 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SMARCA4 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SMARCA4 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SMARCA4 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SMARCA4 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SMARCA4 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SMARCA4 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SMARCA4 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SMARCA4 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SMARCA4 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SMARCA4 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SMARCA4 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SMARCA4 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SMARCA4 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SMARCA4 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for SMARCA4 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SMARCA4 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SMARCA4 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing SMARCA4 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| NURSA Protein-Protein Interactions | interacting proteins for SMARCA4 from the NURSA Protein-Protein Interactions dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with SMARCA4 gene from the curated OMIM Gene-Disease Associations dataset. | |
| PANTHER Pathways | pathways involving SMARCA4 protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SMARCA4 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SMARCA4 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SMARCA4 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SMARCA4 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SMARCA4 protein from the Wikipathways PFOCR 2024 dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate SMARCA4 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving SMARCA4 protein from the PID Pathways dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of SMARCA4 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2014 | pathways involving SMARCA4 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SMARCA4 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SMARCA4 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SMARCA4 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SMARCA4 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SMARCA4 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SMARCA4 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SMARCA4 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SMARCA4 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with SMARCA4 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SMARCA4 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of SMARCA4 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of SMARCA4 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SMARCA4 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SMARCA4 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SMARCA4 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SMARCA4 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SMARCA4 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SMARCA4 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SMARCA4 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SMARCA4 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SMARCA4 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SMARCA4 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| Virus MINT Protein-Viral Protein Interactions | interacting viral proteins for SMARCA4 from the Virus MINT Protein-Viral Protein Interactions dataset. | |
| Virus MINT Protein-Virus Interactions | viruses interacting with SMARCA4 from the Virus MINT Protein-Virus Interactions dataset. | |
| WikiPathways Pathways 2014 | pathways involving SMARCA4 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SMARCA4 protein from the WikiPathways Pathways 2024 dataset. | |